Discover how leading R&D teams use Cypris Q to monitor technology landscapes and identify opportunities faster - Book a demo Executive Summary GLP-1based obesity pharmacotherapy has evolved from single-hormone appetite suppression into a platform competition spanning poly-agonist biology, delivery convenience, and body-composition optimization
* Correspondence: Haigang Ding, [email protected] These authors share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Omada, which supports diabetes, obesity, hypertension and musculoskeletal conditions, launched its GLP-1 Care Track in 2023 in response to client requests
He also revealed that he is a big fan of certain peptides and has used them himself to help with injuries
In addition, SPT impairs postnatal growth, development, and the survival of lambs during the postnatal period (Turgut et al., 2025b)
But that protection assumes refrigeration
